Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | INBS |
---|---|---|
09:32 ET | 4627 | 4.45 |
09:34 ET | 500 | 4.49 |
09:36 ET | 529 | 4.413 |
09:38 ET | 513 | 4.43 |
09:52 ET | 200 | 4.4 |
09:59 ET | 300 | 4.42 |
10:08 ET | 1354 | 4.425 |
10:10 ET | 215 | 4.48 |
10:12 ET | 147 | 4.48 |
10:24 ET | 200 | 4.48 |
10:33 ET | 850 | 4.43 |
10:44 ET | 551 | 4.47 |
10:57 ET | 100 | 4.4744 |
11:02 ET | 1312 | 4.52 |
11:09 ET | 911 | 4.54 |
11:11 ET | 300 | 4.535 |
11:18 ET | 300 | 4.52 |
11:29 ET | 100 | 4.55 |
11:31 ET | 200 | 4.56 |
11:33 ET | 249 | 4.53 |
11:36 ET | 300 | 4.53 |
11:38 ET | 607 | 4.53 |
11:40 ET | 2273 | 4.52 |
11:42 ET | 100 | 4.51 |
11:49 ET | 129 | 4.565 |
11:54 ET | 900 | 4.565 |
12:12 ET | 500 | 4.54 |
12:32 ET | 100 | 4.5554 |
12:36 ET | 100 | 4.51 |
12:39 ET | 120 | 4.53 |
12:41 ET | 750 | 4.54 |
12:43 ET | 400 | 4.55 |
12:45 ET | 100 | 4.575 |
12:48 ET | 100 | 4.575 |
12:50 ET | 1000 | 4.575 |
12:52 ET | 1725 | 4.57 |
01:03 ET | 200 | 4.64 |
01:06 ET | 498 | 4.62 |
01:15 ET | 2930 | 4.5 |
01:30 ET | 297 | 4.52 |
01:32 ET | 100 | 4.57 |
01:33 ET | 200 | 4.53 |
01:35 ET | 100 | 4.53 |
01:39 ET | 4998 | 4.41 |
03:02 ET | 2185 | 4.34 |
03:09 ET | 200 | 4.31 |
03:23 ET | 964 | 4.3 |
03:39 ET | 999 | 4.3 |
03:56 ET | 611 | 4.27 |
03:59 ET | 358 | 4.22 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Intelligent Bio Solutions Inc | 12.7M | 0.0x | --- |
VBI Vaccines Inc | 13.7M | -0.1x | --- |
BioCardia Inc | 10.7M | -0.7x | --- |
ELEVAI Labs Inc | 12.0M | -3.2x | --- |
Imunon Inc | 13.2M | -0.5x | --- |
ABVC Biopharma Inc | 12.7M | -0.5x | --- |
Intelligent Bio Solutions Inc. is a life sciences company. The Company is engaged in developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. It operates through two segments, namely Commercially available Intelligent Fingerprinting Products (IFPG) and Development Stage Saliva Glucose Biosensor Platform (SGBP). Its product portfolio includes a portable drug screening system that works by analyzing fingerprint sweat using a one-time cartridge and portable handheld reader and also includes a development stage range of biosensor- based Point of Care diagnostic tests (POCT) that are developed in the modalities of clinical chemistry, immunology, tumor markers, allergens, and endocrinology. Its product candidate is the Saliva Glucose Biosensor (SGB), a POCT expected to substitute the finger pricking invasive blood glucose monitoring for diabetic patients. Its Biosensor Platform helps to detect multiple biological analytes.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $12.7M |
---|---|
Revenue (TTM) | $2.5M |
Shares Outstanding | 2.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-131.37 |
Book Value | $19.57 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 5.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -559.42% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.